<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03198767</url>
  </required_header>
  <id_info>
    <org_study_id>CLIK066B2203</org_study_id>
    <nct_id>NCT03198767</nct_id>
  </id_info>
  <brief_title>Effects of Carbohydrate in Diet and Supplements on the GI Tolerability of LIK066</brief_title>
  <official_title>A Randomized, Open Label, Two-part, Three-period, Cross Over Study to Investigate the Effects of Carbohydrate in Diet and to Evaluate Supplements on the Gastrointestinal Tolerability of LIK066 in Overweight or Obese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if LIK066 taken with a meal containing low
      carbohydrate is associated with less diarrhea compared to a high carbohydrate meal and to
      assess the potential effects of supplements such as psyllium or calcium carbonate on
      alleviating diarrhea associated with LIK066.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 21, 2017</start_date>
  <completion_date type="Actual">September 4, 2017</completion_date>
  <primary_completion_date type="Actual">September 4, 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of episodes of diarrhea (Part A and Part B)</measure>
    <time_frame>Day 3 of each treatment period</time_frame>
    <description>Episodes of diarrhea is defined as the total number of stools with a Bristol Stool Chart Score of 6 or 7 on day 3 of each treatment period.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average consistency with Bristol stool chart (Part A and Part B)</measure>
    <time_frame>24 hour on Day 3 of each treatment period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average stool pH (Part A and Part B)</measure>
    <time_frame>24 hour on Day 3 of each treatment period</time_frame>
    <description>Average PH of Stool will be reported</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average stool weight (Part A and Part B)</measure>
    <time_frame>24 hour on Day 3 of each treatment period</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>LIK066 + 50% CHO</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LIK066 + 50% carbohydrate breakfast</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LIK066+ 25% CHO</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LIK066+ 25% carbohydrate breakfast</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LIK066 + 0% CHO</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LIK066 + 0% carbohydrate breakfast</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LIK066 + 50% CHO + psyliium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LIK066 + 50% Carbohydrate + 6 grams psyllium at breakfast</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LIK066 + 50% CHO + calcium carbonate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LIK066 + 50% carbohydrate + 1 gram calcium carbonate at breakfast</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LIK066 + 50% CHO + No Supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LIK066 + 50% carbohydrate + no supplement (NS)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LIK066</intervention_name>
    <description>LIK066 with added breakfast type and supplement</description>
    <arm_group_label>LIK066 + 50% CHO</arm_group_label>
    <arm_group_label>LIK066+ 25% CHO</arm_group_label>
    <arm_group_label>LIK066 + 0% CHO</arm_group_label>
    <arm_group_label>LIK066 + 50% CHO + psyliium</arm_group_label>
    <arm_group_label>LIK066 + 50% CHO + calcium carbonate</arm_group_label>
    <arm_group_label>LIK066 + 50% CHO + No Supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  obese and overweight, BMI 25-50, HbA1C &lt;10%

        Exclusion Criteria:

          -  Preexisting, clinically significant cardiovascular, liver, renal, or GI disease that
             is considered unstable; pregnancy, Type 1 diabetes; Other protocol-defined
             inclusion/exclusion criteria may apply
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Novartis Pharmaceuticals</last_name>
    <role>Study Director</role>
    <affiliation>Novartis Pharmaceuticals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2017</study_first_submitted>
  <study_first_submitted_qc>June 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2017</study_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>overweight</keyword>
  <keyword>body mass index</keyword>
  <keyword>BMI</keyword>
  <keyword>diarrhea</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium Carbonate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

